Securities code: Jinhe Biotechnology Co.Ltd(002688) securities abbreviation: Jinhe Biotechnology Co.Ltd(002688) Announcement No.: 2022018 Jinhe Biotechnology Co.Ltd(002688)
The company shall be responsible for the accuracy, omission and misleading of the contents of the annual announcement of the board of directors held in 2021 or the material statements of the board of directors held in the online announcement and report, and shall bear the responsibility for the truthfulness of the annual announcement of the board of directors held in 2021.
Jinhe Biotechnology Co.Ltd(002688) (hereinafter referred to as “the company”) will hold the 2021 annual performance presentation on panorama.com from 15:00 to 17:00 p.m. on Friday, May 13, 2022. This annual performance presentation will be held remotely. Investors can log in to panorama.com’s “investor relations interactive platform”（ https://ir.p5w.net. ）Participate in this annual performance briefing.
Present at the briefing were Mr. Wang Dongxiao, chairman of the company, Mr. Xie Changxian, director and general manager, Mr. Niu Youshan, chief financial officer, Mr. Lu Manman, Secretary of the board of directors and Mr. Lu Wenbing, independent director. In order to fully respect investors and improve the pertinence of exchanges, we are now soliciting questions from investors in advance for the company’s 2021 annual performance description, and widely listen to the opinions and suggestions of investors. Investors can visit before 15:00 on May 12, 2022 https://ir.p5w.net./zj/ , or scan the QR code below to enter the question collection topic page. Investors are kindly requested to submit your concerns through the panorama system, so that the company can answer the questions generally concerned by investors at the performance briefing and improve the pertinence of the performance briefing. During the exchange of this activity, investors can still log in to the activity interface for interactive questions.
Investors are welcome to actively participate in this online briefing.
(QR code of issue collection topic page)
It is hereby announced.
Jinhe Biotechnology Co.Ltd(002688)
Board of directors
April 20, 2022
